Literature DB >> 15717953

Asymptomatic valvular disease: who benefits from surgery?

Naomi F Botkin1, Paula S Seth, Gerard P Aurigemma.   

Abstract

Routine physical examination and noninvasive imaging frequently lead to the diagnosis of valvular heart disease in asymptomatic patients. The decision to proceed to surgical repair or replacement is based on an informed evaluation of the risks of surgery versus those encountered with a nonoperative course. In determining whether symptoms are present, stress testing may be helpful, as many patients with significant valvular lesions have a tendency to limit their daily physical exertion to levels that do not provoke symptoms. The two most feared consequences of conservative management, sudden death and permanent myocardial damage, are rare in asymptomatic patients with severe aortic stenosis or regurgitation. Surgery for asymptomatic aortic stenosis is performed only for certain high-risk subsets of patients, including those with left ventricular dysfunction, ventricular arrhythmia, and critically small valves. Asymptomatic patients with aortic regurgitation and mitral regurgitation should undergo surgery if they have systolic dysfunction or marked ventricular enlargement.

Entities:  

Mesh:

Year:  2005        PMID: 15717953     DOI: 10.1007/s11886-005-0018-2

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  40 in total

Review 1.  Mechanical cardiac valvular prostheses.

Authors:  C W Akins
Journal:  Ann Thorac Surg       Date:  1991-07       Impact factor: 4.330

2.  Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography.

Authors:  J L Monin; M Monchi; V Gest; A M Duval-Moulin; J L Dubois-Rande; P Gueret
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

3.  Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

Authors:  G M Novaro; I Y Tiong; G L Pearce; M S Lauer; D L Sprecher; B P Griffin
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

4.  Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing.

Authors:  M C Amato; P J Moffa; K E Werner; J A Ramires
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

5.  Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

Authors:  Ivor L Gerber; Ralph A H Stewart; Malcolm E Legget; Teena M West; Renelle L French; Timothy M Sutton; Timothy G Yandle; John K French; A Mark Richards; Harvey D White
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

6.  Natural history and left ventricular response in chronic aortic regurgitation.

Authors:  K Ishii; Y Hirota; M Suwa; Y Kita; H Onaka; K Kawamura
Journal:  Am J Cardiol       Date:  1996-08-01       Impact factor: 2.778

7.  HMG CoA reductase inhibitor (statin) and aortic valve calcium.

Authors:  David M Shavelle; Junichuro Takasu; Matthew J Budoff; SongShou Mao; Xue Qiao Zhao; Kevin D O'Brien
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

8.  Prophylactic mitral reconstruction for mitral regurgitation.

Authors:  I A Smolens; F D Pagani; G M Deeb; R L Prager; S S Sonnad; S F Bolling
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

9.  Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Authors:  R O Bonow; B Carabello; A C de Leon; L H Edmunds; B J Fedderly; M D Freed; W H Gaasch; C R McKay; R A Nishimura; P T O'Gara; R A O'Rourke; S H Rahimtoola; J L Ritchie; M D Cheitlin; K A Eagle; T J Gardner; A Garson; R J Gibbons; R O Russell; T J Ryan; S C Smith
Journal:  Circulation       Date:  1998-11-03       Impact factor: 29.690

10.  Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function.

Authors:  R O Bonow; E Lakatos; B J Maron; S E Epstein
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

View more
  2 in total

1.  Wave mice: a new tool in the quest to characterize aortic valvular disease etiologies.

Authors:  Ana M Porras; Kristyn S Masters
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  Impact of chronic kidney disease on clinical outcomes in patients with Stage B progressive aortic regurgitation (mild to moderate and moderate grades).

Authors:  Ji-Won Hwang; Dong-Gil Kim; Hakju Kim; Jae-Jin Kwak; Sung Woo Cho; Da Mi Bae; Yoon Cheol Shin; Joon Hyung Doh; Sung Uk Kwon; June Namgung; Sung Yun Lee
Journal:  Clin Cardiol       Date:  2022-02-16       Impact factor: 3.287

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.